运动值参数不能预测重复的跨体磁性刺激和间歇性的Teta爆发刺激在重大抑郁症障碍中的结果
Noah A Lee1, Simon Kung2, Brandan K Penaluna2
1Mayo Clinic Alix School of Medicine, 4500 San Pablo Road, Jacksonville, FL 32224, USA.
Journal of affective disorders
|December 5, 2024
概括
运动值和治疗强度不能预测重度抑郁症 (MDD) 患者的结果,这些患者接受重复性跨磁刺激 (rTMS) 或间歇性甲突发刺激 (iTBS). 患者的舒适感,而不是刺激强度,似乎是治疗有用性的关键.
科学领域:
- 神经调节是一种神经调节.
- 精神病学是一个精神病学.
- 临床神经科学 临床神经科学
背景情况:
- 重复性跨磁刺激 (rTMS) 和间歇性甲基突发刺激 (iTBS) 是已确立的大型抑郁症 (MDD) 的非侵入性治疗方法.
- 由于结果的可变性,预测MDD患者接受TMS的治疗反应至关重要.
- 这项研究研究了运动值 (MT),运动值百分比 (%MT) 和治疗强度作为临床结果的潜在预测因素.
研究的目的:
- 确定运动值 (MT),MT%和治疗强度是否预测MDD患者的临床结果.
- 评估TMS参数与治疗反应,缓解和患者报告的帮助之间的关系.
- 为了确定影响抑郁症非侵入性脑刺激治疗疗效的因素.
主要方法:
- 分析了使用NeuroStar rTMS或iTBS治疗的成人MDD患者 (N=149).
- 记录了运动值 (MT),MT%和治疗强度.
- 测量的临床结果包括患者健康问卷-9 (PHQ-9) 评分变化,反应,缓解,以及患者报告的帮助性结果 (PRO);使用了回归模型.
主要成果:
- 无论是MT还是%MT都与临床结果没有显著的相关性.
- 治疗强度和TMS类型没有预测PHQ-9分数的变化.
- 较高的治疗强度与积极的PRO反应的几率下降有关;年龄和性别预测PHQ-9变化.
结论:
- MT,%MT和治疗强度不是MDD中TMS治疗结果的可靠预测指标.
- 更高的刺激强度可能会减少患者报告的帮助力,强调患者舒适的重要性.
- 需要进行进一步的研究,以确定优化TMS治疗主要抑郁症治疗的强有力的预测因子.
相关概念视频
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation
8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K


